Curcumin: A new candidate for retinal disease therapy?. Issue 5 (11th December 2018)

• Record Type: Journal Article
• Authors: Farajipour, Hasan; Rahimian, Susan; Taghizadeh, Mohsen
• Is Part Of: Journal of cellular biochemistry. Volume 120:Issue 5(2019)
• Page Start: 6886
• Page End: 6893
• Publication Date: 2018-12-11
• Subjects: curcumin -- retina diseases -- therapy; Cytochemistry -- Periodicals; 572
• DOI: 10.1002/jcb.28068
• Languages: English
• ISSNs: 0730-2312

Abstract

Abstract: The retina is the neural portion and light‐sensitive layer of the eye, which has been observed in most of the vertebrates. The retina is composed of light‐sensitive cells that absorb light and convert it into neural signals. These signals are sent to the brain for visual recognition. It has been shown that many pathogenesis conditions, including inflammation, angiogenesis, oxidative stress, and imbalanced histone modifications in the retina are associated with initiation and progression of retinal diseases (ie, glaucoma, diabetic retinopathy, and age‐related macular degeneration). Currently available treatments include laser surgery, freezing, stem‐cell therapy, shrinking abnormal blood vessels. It has some limitations, such as invasive methods, high costs, and many side effects. Hence, finding a new therapeutic platform for stopping or slowing of the disease progression is required. Curcumin is a natural product, which is associated with a wide range of properties, such as antioxidant, anti‐inflammatory, antiangiogenic, and antitumor activates. It exerts therapeutic effects via activation/inhibition cellular and molecular targets involved in various diseases, such as retinal diseases. Increasing evidence revealed that curcumin can be used as a therapeutic option in the treatment of different retinal diseases. Here, we summarized various clinical and preclinical studies that used curcumin as a therapeutic agent in the treatment of retinal disorders.